PHARMA LITERATI

We are looking for Mumbai/ Thane/ Navi Mumbai students to join our team of professionals. If you want to shine in your career in the years ahead or study abroad, this is a golden opportunity to make your base solid. Think beyond the lectures/ practicals/ seminars/ workshops/ conferences. Come join us for an exciting opportunity ahead.  Pharma Literati is pleased to announce the internship opportunities for undergraduate/ post-graduate students in pharmacy/ life sciences domain.  Looking for passionate, career-focused, highly motivated individuals who wish to join the dynamic team of Pharma Literati.  Profile:  The students would work with a dynamic team of professionals and help Pharma Literati team in their endeavors to manage and co-ordinate -         Pharma Innovation Yatra; -         CPIPR course; -      Upcoming cou...

In another new effort to bridge gap between industry and academia, team pharma literati is launching a new regular feature for our readers.  Are you an intern? Have you completed your internship at any institute or company or R & D or Marketing recently? Here is a golden opportunity for all to share your experience of internship with the world.  Those who finished their internship after 1st Jan. 2017 are eligible for this feature.  What would you get? 1. A free (No conditions applied, it's absolutely free) registration to one of our courses under the aegis of Pharma Literati Centre of Excellence for Pharma Education. 2. Your internship experience would be published along with your name and photograph on Pharma Literati blog.  3. You get an alumni status for Pharma Literati C entre of Excellence for Pharma Education. How would the pharma community get benefited? 1. The pharma community gets benefited, especially the students by your you...

A day-long meet on draft pharmaceutical policy is called by department of pharmaceuticals (DoP) on August 30 in New Delhi to discuss key aspects of the policy with representative bodies of pharmaceutical industry and trade. Representatives from IPA, IDMA, BDMA, FOPE, OPPI, CIPI, FICCI, ASSOCHAM, CII, PHD, Pharmexcil, AIDAN, Nathealth, Prayas, Consumer Connexion, LOCOST, JSA, AIOCD, AICDF, Consumer India have been invited for the conference. The inaugural session of the  meet will be addressed by Sudhansh Pant, joint secretary of DoP, Jai Priye Prakash, secretary of DoP, CK Mishra, secretary of ministry of health and family welfare, Ramesh Abhishek, secretary of department of industrial policy and promotion, Rita Teaotia, secretary, department of commerce, Ajay Narayan Jha, secretary, ministry of environment, forests and climate change, Bhpendra Singh, chairman of National Pharmaceutical Pricing Authority, Rajneesh Tingal, joint secretary of DoP. Divided into four sess...

Team pharma Literati has recently announced the launch of  Certificate course in Pharmaceutical Intellectual Property Rights (CPIPR).  We are providing complimentary registrations for  1. Winners of 1st Annual Pharma Literati essay contest: http://pharmaliterati.blogspot.in/2017/02/1st-annual-pharma-literati-essay.html 2. Faculty members who were part of workshop on "Teaching with animations" http://pharmaliterati.blogspot.in/2017/05/faculty-training-workshop-on-teaching.html 3. One complimentary registration for the institutes who were part of Pharma Innovation yatra.  http://pharmaliterati.blogspot.in/2017/07/pharma-innovation-yatrajuly-2017.html Emails have been already sent to the concerned with the promo code details. If anyone hasn't received the email, please get in touch with us at pharmaliterati@gmail.com

Registration forms for Certificate course in Pharmaceutical Intellectual Property Rights (CPIPR) are now available. CPIPR is a unique initiative under the aegis of Pharma Literati centre of Excellence of Pharma Education. https://docs.google.com/forms/d/1jhe8j827624EASMxq2fnOLifC2O1NpS6p1xQ49DUf_U/viewform?edit_requested=true There are limited registrations available for the course. For discounts and any further enquiries write back to us to pharmaliterati@gmail.com or call us on 8850949256 . Frequently asked questions: What is the last date of registration? 15th September 2017. How shall I make the payment? Online transfers and cheques or DDs are accepted . Please send an email, call or WhatsApp for the account details . The account details are available on the link of registration form.   How would I get the notifications about the courses? Via registered mobile number, you would receive the SMS notifications about, ·   ...

We have recently announced the launch of Certificate course in Pharmaceutical Intellectual Property Rights (CPIPR). The faculty for the same is Mr. Mayank Gupta. Mr. Mayank Gupta is currently serving as  Manager, IPR, Sun Pharma . He carries with him more than 8 years of experience in IPR with leading pharmaceutical organizations like Glenmark and Lupin pharma. M-Pharm from BITS, Pilani, Mayank is an IPR expert with the expertise in generics as well as innovation. He is also a registered patent agent with the Indian Patent Office.  For details of the course, please see:  http://pharmaliterati.blogspot.in/2017/08/certificate-course-in-pharmaceutical.html

Pharma Literati Centre of Excellence of Pharma Education is pleased to announce its first offering . First of its kind of a course being delivered by the industry experts  " Certificate Course in Pharmaceutical Intellectual Property Rights ( CPIPR )".   For whom? Pharmacy/ Chemistry/ Biosciences/ Life sciences/ Biotechnology/ Zoology/ Botany students in undergraduate/ post graduate / PhD/ Research fellows; Faculties form any of these streams; Industry professionals** from Pharma/ Biotechnology/ Life sciences; Anyone who is willing to make a career in R & D; Business development; International Business; Drug discovery; Generic drug development; Academic research; Regulatory affairs; Intellectual Property Rights and the like; Students willing to pursue higher studies in USA/Europe/ Canada/ Australia/ Russia/ Korea/ Japan/ other countries as PhD/ MBA/ MS/ Masters. ** Since this is a basic level course, it is design...

On 19th August 2017, the Pharma Innovation Yatra reached the beautiful city of Karjat, near Mumbai. A session on creative thinking and innovation was conducted at the institute. This marks the 13th session of the Yatra, which is a Pharma Literati initiative.  The sessions were attended by over 100 students of 3rd year and final year B. pharmacy.  Pharma Innovation yatra is already conducted at various places in Maharashtra and Gujarat.  Please see:  http://pharmaliterati.blogspot.in/2017/07/pharma-innovation-yatrajuly-2017.html Pharma Literati team is planning to conduct the session at various institutes in next couple of months. Five more sessions are in the pipeline in the upcoming month. We are still accepting the invites to conduct the sessions at various institutes. The programs are free of cost. Please write an email to pharmaliterati@gmail.com if you wish us to conduct the program at your institute to confirm the date.

The prices of medicines will soon bend in the service to the government’s ‘ease of doing business’ and ‘Make in India’ programmes, if the proposals in the Draft Pharmaceutical Policy, 2017 are accepted. The Draft Policy, which BusinessLine has seen, calls for ‘re-orientation’ of the Drug Price Control Order (DPCO) from “price-control to monitoring of drug prices”. The Draft, which focuses heavily on prices of medicine, has proposed massive dilutions in the existing framework, which would give more control to the government over the operations of the National Pharmaceutical Pricing Authority (NPPA), which till now functions as an autonomous body. It also attempts to strip the NPPA of some powers, for instance, once the price for a drug is fixed the pricing authority would not be allowed to revise them. The NPPA would also lose its power to cap the prices of in-patent medicines, and would be able to use its “emergency powers” only on the government’s orders. “This Polic...

Over the years, with more and more of the Indian pharmaceuticals industry subjected to different forms of price control, firms have focused more on the overseas business - from 43% of industry revenues in FY11, the domestic industry has been reduced to 34% in FY16. While the government has seized upon this lowering of growth of the domestic industry - in its draft pharmaceuticals policy - it has misdiagnosed the problem, compounded this with goals that are contradictory, and come out with a diagnosis designed to make things worse. After prefacing the statement by saying “ India is also called the ‘pharmacy of the world’ and renowned for very high quality drugs at very cost competitive prices ”, the rest of the policy is dedicated to finding ways to tighten existing price controls. That these price controls are the reason for many of the problems the policy talks of - less emphasis on R&D, excessive use of foreign raw materials and non-adherence to quality standards - escapes the ...

What MANTHAN:       INDUSTRY - ACADEMIA CONCLAVE Addressing National Trends in Harmonizing Norms in Drug Research Where CDRI, Lucknow, Uttar Pradesh When 15 th and 16 th September 2017 For whom Stakeholders in the discovery of small-molecule drugs, phytopharmaceuticals, formulations etc Details http://cdri.res.in/IndustryMeet/Manthan.pdf Deadline 31 st August 2017